T. Rowe Price Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.34M | Buy |
|
|||||
|
2025
Q2 | $6.28M | Sell |
|
|||||
|
2025
Q1 | $15.7M | Sell |
|
|||||
|
2024
Q4 | $21M | Sell |
|
|||||
|
2024
Q3 | $27.6M | Sell |
|
|||||
|
2024
Q2 | $23.4M | Sell |
|
|||||
|
2024
Q1 | $25.7M | Sell |
|
|||||
|
2023
Q4 | $36.3M | Buy |
|
|||||
|
2023
Q3 | $26.2M | Buy |
|
|||||
|
2023
Q2 | $29.1M | Buy |
|
|||||
|
2023
Q1 | $17.6M | Sell |
|
|||||
|
2022
Q4 | $22.1M | Sell |
|
|||||
|
2022
Q3 | $22.7M | Buy |
|
|||||
|
2022
Q2 | $5.66M | Buy |
|